Harrow Inc HROW:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/16/24 EDT
15.83quote price arrow down-0.33 (-2.04%)
Volume
8,577
Close
16.16UNCH (UNCH)
Volume
504,286
52 week range
7.60 - 24.19
Loading...
  • Open15.91
  • Day High16.37
  • Day Low15.78
  • Prev Close16.16
  • 52 Week High24.19
  • 52 Week High Date05/25/23
  • 52 Week Low7.60
  • 52 Week Low Date11/14/23

Key Stats

  • Market Cap571.767M
  • Shares Out35.38M
  • 10 Day Average Volume0.72M
  • Dividend-
  • Dividend Yield-
  • Beta0.85
  • YTD % Change44.29

KEY STATS

  • Open15.91
  • Day High16.37
  • Day Low15.78
  • Prev Close16.16
  • 52 Week High24.19
  • 52 Week High Date05/25/23
  • 52 Week Low7.60
  • 52 Week Low Date11/14/23
  • Market Cap571.767M
  • Shares Out35.38M
  • 10 Day Average Volume0.72M
  • Dividend-
  • Dividend Yield-
  • Beta0.85
  • YTD % Change44.29

RATIOS/PROFITABILITY

  • EPS (TTM)-0.91
  • P/E (TTM)-17.80
  • Fwd P/E (NTM)-48.82
  • EBITDA (TTM)4.772M
  • ROE (TTM)-76.01%
  • Revenue (TTM)138.677M
  • Gross Margin (TTM)69.77%
  • Net Margin (TTM)-22.59%
  • Debt To Equity (MRQ)304.07%

EVENTS

  • Earnings Date08/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Harrow Inc

 

Profile

MORE
Harrow, Inc. is an eyecare pharmaceutical company. The Company is engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the United States market. It provides a comprehensive portfolio of prescription and non-prescription pharmaceutical products. It owns commercial rights to portfolios of branded ophthalmic pharmaceutical products in North America, all of which are marketed under the Harrow name. It owns and operates ImprimisRx...
Mark Baum J.D.
Chairman of the Board, Chief Executive Officer
Andrew Boll
Chief Financial Officer, Corporate Secretary
Address
102 WOODMONT BLVD, SUITE 610
Nashville, TN
37215
United States

Top Peers

SYMBOLLASTCHG%CHG
TVTX
Travere Therapeutics Inc
6.69UNCHUNCH
SIGA
SIGA Technologies Inc
7.90UNCHUNCH
ESPR
Esperion Therapeutics Inc
2.59UNCHUNCH
CDXC
Chromadex Corp
3.48UNCHUNCH
ASRT
Assertio Holdings Inc
1.02UNCHUNCH